BioSpace News Archive

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer’s Disease research, has announced that the last patient has completed treatment in the blinded phase of their late-stage clinical trial, Lucidity.

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first commercial doses of its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection.

In “Innovations in Neuromodulation,” the International Neuromodulation Society (INS) brings together industry leaders, innovators and investors May 22 to discuss commercialization from a global perspective.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced two updates regarding Nurtec® ODT (rimegepant), the only FDA-approved medication to both treat and prevent migraine attacks in adults.

Shanghai Fosun Pharmaceutical announced that the Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) self-developed by Fosun Diagnostics Co., Ltd. has received approval from the China’s National Medical Products Administration (NMPA) for the commercial and clinical use of rapid antigen testing in COVID-19 screening.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will release financial results for the first quarter of 2022 after the market close on Thursday, May 5th, 2022.

Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, Chief Financial Officer and co-interim Chief Executive Officer, will present a Company overview at the NobleCon18 Conference on Thursday, April 21, 2022 at 9:30 a.m. Eastern Time.

Cidara Therapeutics, Inc. and Mundipharma today announced that the companies will present new clinical data and analyses of rezafungin, a novel, once-weekly echinocandin in development for the treatment of candidemia and invasive candidiasis and prevention of invasive fungal infections, at the 32nd European Congress of Clinical Microbiology and Infectious Diseases.

Daré Bioscience, Inc. announced that Sabrina Martucci Johnson, the company’s President and CEO, will participate in a panel discussion at the Innovations in Women’s Health Business Conference to be held on April 21, 2022 at Westin Copley Place in Boston, Massachusetts.

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2022 Annual Meeting of Stockholders.